1. Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate
   Mattias F. Lindberg et al, 2023, Journal of Medicinal Chemistry CrossRef
2. Design, synthesis, and structure–activity relationship studies of 6H-benzo[b]indeno[1,2-d]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors
   Abdelfattah Faouzi et al, 2024, RSC Medicinal Chemistry CrossRef